| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |